Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments

v3.2.0.727
Derivative Financial Instruments
6 Months Ended
Aug. 01, 2015
Derivative Financial Instruments  
Derivative Financial Instruments

 

12.  Derivative Financial Instruments

 

As discussed in Note 4, in January 2015, we entered into an interest rate swap agreement on a notional amount of $520.0 million that matures in August 2018 with periodic interest settlements.  We have designated the interest rate swap as a cash flow hedge of the variability of interest payments under the Term Loan due to changes in the LIBOR benchmark interest rate.  At August 1, 2015, the fair value of the interest rate swap was a liability of $2.9 million with $2.5 million recorded in accrued expenses and other current liabilities and $0.4 million in other liabilities in our consolidated balance sheet.  The effective portion of the swap is reported as a component of accumulated other comprehensive income.  There was no hedge ineffectiveness at August 1, 2015.  Changes in fair value are reclassified from accumulated other comprehensive income into earnings in the same period that the hedged item affects earnings.

 

Over the next 12 months, $2.5 million of the effective portion of the interest rate swap is expected to be reclassified from accumulated other comprehensive income into earnings.  If, at any time, the interest rate swap is determined to be ineffective, in whole or in part, due to changes in the interest rate swap or underlying debt agreements, the fair value of the portion of the interest rate swap determined to be ineffective will be recognized as a gain or loss in the statement of earnings for the applicable period.